Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

February 2015 Archives

Newly published study links Zoloft to birth defects

While more than 500 Zoloft lawsuits are pending before the U.S. District Court for the Eastern District of Pennsylvania for pretrial management, a Canadian study that the American Journal of Obstetrics and Gynecology released Jan. 28 showed an association between an expectant mother's use of Zoloft during pregnancy and the emergence of birth defects.

Newly published study links Zoloft to birth defects

While more than 500 Zoloft lawsuits are pending before the U.S. District Court for the Eastern District of Pennsylvania for pretrial management, a Canadian study that the American Journal of Obstetrics and Gynecology released Jan. 28 showed an association between an expectant mother's use of Zoloft during pregnancy and the emergence of birth defects.

Crusade launched against uterine fibroid procedure

To the U.S. Food and Drug Administration, the risk that a uterine fibroid surgical treatment poses is worthy of a warning. But cardiothoracic surgeon Dr. Hooman Noorchashm has made banning the procedure, which is known as laparoscopic power morcellation, a crusade.

Testosterone replacement lawsuits being transferred to Illinois

Indiana plaintiffs who filed a testosterone replacement therapy lawsuit may have their case tried in federal court in Illinois, where 281 similar lawsuits reside. The U.S. Judicial Panel on Multidistrict Litigation on Friday transferred to U.S. District Court for the Northern District of Illinois a lawsuit against Abbvie, Abbott Laboratories and unnamed physicians consistent with a decedent's use of AndroGel.

Testosterone replacement lawsuits being transferred to Illinois

Indiana plaintiffs who filed a testosterone replacement therapy lawsuit may have their case tried in federal court in Illinois, where 281 similar lawsuits reside. The U.S. Judicial Panel on Multidistrict Litigation on Friday transferred to U.S. District Court for the Northern District of Illinois a lawsuit against Abbvie, Abbott Laboratories and unnamed physicians consistent with a decedent's use of AndroGel.

Xarelto cited in clinical trial 'misconduct' report

The respected medical journal JAMA Internal Medicine published a report Feb. 9 citing instances in which the U.S. Food and Drug Administration uncovered "misconduct" in the way clinical trials to test the efficacy of drugs are carried out. Sure enough, FDA inspections of clinical trials for the drug rivaroxaban, which goes by the brand name Xarelto, found irregularities.

Xarelto cited in clinical trial 'misconduct' report

The respected medical journal JAMA Internal Medicine published a report Feb. 9 citing instances in which the U.S. Food and Drug Administration uncovered "misconduct" in the way clinical trials to test the efficacy of drugs are carried out. Sure enough, FDA inspections of clinical trials for the drug rivaroxaban, which goes by the brand name Xarelto, found irregularities.

Duodenoscopes under FDA scrutiny

It is possible that the "complex design" of duodenoscopes may make them hard to clean, to disinfect, and to sterilize, thus infection-prone. That assessment is from the U.S. Food and Drug Administration, not from any law firm, which issued a safety communication Feb. 19 in regard to the medical devices. These devices are described technically as Endoscopic Retrograde Cholangiopancreatography, or ERCP, endoscopes.

Duodenoscopes under FDA scrutiny

It is possible that the "complex design" of duodenoscopes may make them hard to clean, to disinfect, and to sterilize, thus infection-prone. That assessment is from the U.S. Food and Drug Administration, not from any law firm, which issued a safety communication Feb. 19 in regard to the medical devices. These devices are described technically as Endoscopic Retrograde Cholangiopancreatography, or ERCP, endoscopes.

Nizoral may cause adrenal, liver injury

First the U.S. Food and Drug Administration limited a certain antifungal drug's use, and now an advocacy group has called for its removal in oral form from the market. The drug is ketoconazole, which is sold under the brand name Nizoral. The drug, which has been made and marketed by Janssen Pharmaceuticals, has been linked to liver and adrenal injuries.

Nizoral may cause adrenal, liver injury

First the U.S. Food and Drug Administration limited a certain antifungal drug's use, and now an advocacy group has called for its removal in oral form from the market. The drug is ketoconazole, which is sold under the brand name Nizoral. The drug, which has been made and marketed by Janssen Pharmaceuticals, has been linked to liver and adrenal injuries.

FDA cracks down on weight-loss supplement

Reporting that it contains an antidepressant, the U.S. Food and Drug Administration since Feb. 28 has been urging consumers "not to purchase or use" a weight-loss supplement previously linked to liver damage. The supplement is called Oxy Elite Pro Super Thermogenic. The agency learned in its laboratory analysis that a particular lot of the product contained fluoxetine, the generic selective serotonin reuptake inhibitor sold under the brand name Prozac.

FDA cracks down on weight-loss supplement

Reporting that it contains an antidepressant, the U.S. Food and Drug Administration since Feb. 28 has been urging consumers "not to purchase or use" a weight-loss supplement previously linked to liver damage. The supplement is called Oxy Elite Pro Super Thermogenic. The agency learned in its laboratory analysis that a particular lot of the product contained fluoxetine, the generic selective serotonin reuptake inhibitor sold under the brand name Prozac.

Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions